Jeffrey S. Hackman insider trades

Open-market stock purchases and sales by Jeffrey S. Hackman, Chief Executive Officer at Fennec Pharmaceuticals Inc, from SEC Form 4 filings since Aug 9, 2022.

Track record: 100% of 2 scored buys are up 5% or more since purchase, averaging +55%.

Recent trades

DateStockTradeValue
Sep 30, 2026FENC Fennec Pharmaceuticals IncBought (not open market)—
Aug 31, 2026FENC Fennec Pharmaceuticals IncBought (not open market)—
Jul 31, 2026FENC Fennec Pharmaceuticals IncBought (not open market)—
Jun 30, 2026FENC Fennec Pharmaceuticals IncBought (not open market)—
May 31, 2026FENC Fennec Pharmaceuticals IncBought (not open market)—
Apr 30, 2026FENC Fennec Pharmaceuticals IncBought (not open market)—
Mar 31, 2026FENC Fennec Pharmaceuticals IncBought (not open market)—
Mar 31, 2026FENC Fennec Pharmaceuticals IncBought (not open market)—
Mar 31, 2026FENC Fennec Pharmaceuticals IncBought (not open market)$1.2M
Mar 28, 2026FENC Fennec Pharmaceuticals IncBought (not open market)—
Feb 18, 2026FENC Fennec Pharmaceuticals IncBought (not open market)—

Companies traded

  • FENC Fennec Pharmaceuticals Inc: 2 buys, last Sep 30, 2026
  • CMRA Comera Life Sciences Holdings, Inc: 1 buy, last Sep 27, 2023

Get free alerts when Jeffrey S. Hackman files a new trade →